Literature DB >> 9590561

Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats.

O Riah1, P Courrière, J C Dousset, N Todeschi, C Labat.   

Abstract

1. Nicotine and its main metabolite, cotinine, were reported to have distinct behavioral activities in mammals. 2. In this study, cotinine was synthesized without detectable nicotine contamination to compare the ability of nicotine and cotinine to pass the blood-brain barrier (BBB) in rats. 3. The alkaloids were extracted from plasma and brain tissues by methanol, identified by thin-layer chromatography, and quantified by high-pressure liquid chromatography and radioimmunoassays. 4. Consistently, the three methods showed that the passage of cotinine was time, route of administration, and dose dependent and that nicotine was more efficient than cotinine to pass the BBB. 5. The results suggest that these alkaloids may have central activities that probably result from their actions at distinct molecular levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590561     DOI: 10.1023/a:1022501131709

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  22 in total

1.  DISPOSITION AND FATE OF (--)-COTININE-H3 IN THE MOUSE.

Authors:  E R BOWMAN; E HANSSON; L B TURNBULL; H MCKENNIS; C G SCHMITERLOEW
Journal:  J Pharmacol Exp Ther       Date:  1964-03       Impact factor: 4.030

2.  Metabolism of nicotine in the human and excretion of pyridine compounds by smokers.

Authors:  E R BOWMAN; L B TURNBULL; H McKENNIS
Journal:  J Pharmacol Exp Ther       Date:  1959-10       Impact factor: 4.030

3.  The metabolism of nicotine and cotinine by a mouse liver preparation.

Authors:  T Stålhandske
Journal:  Acta Physiol Scand       Date:  1970-02

4.  Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

Authors:  C Reavill; B Walther; I P Stolerman; B Testa
Journal:  Neuropharmacology       Date:  1990-07       Impact factor: 5.250

5.  Pharmacodynamic effects of cotinine in abstinent cigarette smokers.

Authors:  R M Keenan; D K Hatsukami; P R Pentel; T N Thompson; M A Grillo
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

6.  Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.

Authors:  D J Anderson; S P Arneric
Journal:  Eur J Pharmacol       Date:  1994-03-03       Impact factor: 4.432

7.  On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons.

Authors:  K Fuxe; B J Everitt; T Hökfelt
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

8.  Disposition kinetics and effects of intravenous nicotine.

Authors:  J Rosenberg; N L Benowitz; P Jacob; K M Wilson
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

9.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

10.  Intracerebellar nicotinic-cholinergic participation in the cerebellar adenosinergic modulation of ethanol-induced motor incoordination in mice.

Authors:  M S Dar; E R Bowman; C Li
Journal:  Brain Res       Date:  1994-04-25       Impact factor: 3.252

View more
  14 in total

1.  The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors.

Authors:  Ashley M Fox; Faruk H Moonschi; Christopher I Richards
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

2.  Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome.

Authors:  Marta Pardo; Eleonore Beurel; Richard S Jope
Journal:  Eur J Neurosci       Date:  2016-11-12       Impact factor: 3.386

3.  Isolation and microsequencing of a novel cotinine receptor.

Authors:  O Riah; J C Dousset; E Bofill-Cardona; P Courrière
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

4.  The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

Authors:  Alvin V Terry; Jerry J Buccafusco; R Foster Schade; Leah Vandenhuerk; Patrick M Callahan; Wayne D Beck; Elizabeth J Hutchings; James M Chapman; Pei Li; Michael G Bartlett
Journal:  Biochem Pharmacol       Date:  2012-01-08       Impact factor: 5.858

5.  Developmental exposure to vasopressin increases aggression in adult prairie voles.

Authors:  J M Stribley; C S Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  A recursive-partitioning model for blood-brain barrier permeation.

Authors:  S R Mente; F Lombardo
Journal:  J Comput Aided Mol Des       Date:  2005-12-06       Impact factor: 3.686

7.  Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.

Authors:  Xin Zhou; Xiaoliang Zhuo; Fang Xie; Kerri Kluetzman; Yue-Zhong Shu; W Griffith Humphreys; Xinxin Ding
Journal:  J Pharmacol Exp Ther       Date:  2009-11-18       Impact factor: 4.030

8.  Time-course of extracellular nicotine and cotinine levels in rat brain following administration of nicotine: effects of route and ethanol coadministration.

Authors:  Simon N Katner; Jamie E Toalston; Michael P Smoker; Zachary A Rodd; William J McBride; Eric A Engleman
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

Review 9.  New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.

Authors:  J Alex Grizzell; Valentina Echeverria
Journal:  Neurochem Res       Date:  2014-06-27       Impact factor: 3.996

10.  Simultaneous quantification of tobacco alkaloids and major phase I metabolites by LC-MS/MS in human tissue.

Authors:  Lisa Fischer; Felix Mikus; Ricarda Jantos; Gisela Skopp
Journal:  Int J Legal Med       Date:  2014-10-11       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.